Elismetrep
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Elismetrep, covering 2025-09-03 to 2026-08-27. Get the full timeline:
Most recent: Clinical Trial Results: A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine [Phase 2]